All News
Citius Oncology Reports Positive Quality of Life Data for LYMPHIR in CTCL Study
Citius Oncology announced positive health-related quality of life (HRQoL) results from its pivotal Study 302 for LYMPHIR®, a treatment for relapsed or...
🟢 Bitcoin ETF (EBTC.XA) is trading 3.7% up on November 4 as Bitcoin rebounds after midterm result
EBTC.XA is trading at A$11.04, up 3.66%, as Bitcoin rebounded after Democrats won control of Congress and election uncertainty eased. - Markets digested the...
🔴 Electro Optic Systems is trading 7.77% down today amid broad Australian defence-stock losses
Electro Optic Systems is trading at A$7.24 (-7.77%) amid broad weakness in Australian defence stocks. - No company-specific announcement for November 4 was...
🟢 Echo IQ is trading 6.2% up with no clear company-specific catalyst
Echo IQ is trading at A$0.52, up 6.19%, with no clear company-specific catalyst identified for the November 4 move. - The latest ASX notice, released after...
🟢 Dragonfly Energy is trading 6.4% up in after-hours trading amid a post-election renewable-energy rally
Dragonfly Energy is trading at $2.16, up 6.40%, amid a renewable-energy share rally that may have contributed to its November 4 move. - No verified...
🔴 DroneShield is trading 7.6% down on November 4 amid a broad sell-off in Australian defense stocks
DroneShield is trading at A$1.21, down 7.6% on November 4 amid a broader sell-off in Australian defense stocks; no specific company trigger was identified. -...
🟢 Arafura Rare Earths is trading 5.36% up with no clear company-specific catalyst
Arafura Rare Earths is trading 5.36% up at A$0.15, with no clear company-specific announcement identified to explain the move. - The available market context...
🔴 Archer Materials is trading 5.88% down today amid Philadelphia Semiconductor index weakness
Archer Materials is trading 5.88% down at A$0.16, with broader semiconductor weakness a possible backdrop, not an established company-specific catalyst. - The...
🔴 4DMedical is trading 10.79% down with no confirmed catalyst identified
4DMedical is trading at A$2.15, down 10.79%, with no confirmed catalyst identified for the November 4 decline. - 4DMedical previously told the ASX it knew of...
FrontView REIT's third quarter AFFO beat expectations as acquisitions reached $50.6 million target
FrontView REIT reported third quarter 2026 revenue of $18.63 million and adjusted funds from operations (AFFO) of $0.33 per share, beating analyst estimates...
XMAX Shareholders Approve Private Placement and Registered Direct Stock Offerings
XMAX Inc. announced that at a special meeting on November 2, 2026, its shareholders approved proposals authorizing the company to issue significant amounts of...
🟢 Sunrun is trading 10.1% up in after-hours trading after Q3 earnings beat expectations
Sunrun is trading at $9.68, up 10.13%, in after-hours trading after Q3 revenue and earnings exceeded analyst expectations. - Q3 revenue was $1.1 billion and...
🟢 e.l.f. Beauty is trading 4.18% up in after-hours trading after raising fiscal 2027 outlook
e.l.f. Beauty is trading at $118.55, up 4.18% in after-hours trading after strong fiscal Q2 results and raised fiscal 2027 guidance. - Its November 4 fiscal...
🟢 Curtiss-Wright is trading 4.4% up in after-hours trading after Q3 beat and raised guidance
Curtiss-Wright is trading at $471.12, up 4.40%, after a Q3 earnings beat and raised guidance. - Q3 adjusted EPS was $3.94 and revenue was $952.6 million, both...
Stran & Company Announces Date for Third Quarter 2026 Earnings Call
Stran & Company, Inc. (SWAG) announced it will host a conference call to discuss its financial results for the third quarter of 2026 and provide a general...
🟢 Tech ETF (CHAT) is trading 1.64% up in after-hours trading as Democrats’ sweep eases uncertainty
CHAT is trading at $73.86, up 1.64% in after-hours trading as improved risk appetite followed Democrats’ congressional sweep, which eased political uncertainty...
Lyell Immunopharma reports 77% complete response rate for ronde-cel in third quarter 2026
Lyell reported a third quarter 2026 net loss of $45.5 million as it increased investments in its pivotal chimeric antigen receptor (CAR) T-cell therapy trials....
🔴 Paycom Software is trading 8.9% down in after-hours trading after Q3 results; specific catalyst unclear
Paycom Software is trading at $243.70, down 8.92%, after Q3 results; available reporting does not identify a specific earnings detail as the cause of the...
Annovis Bio Stockholders Approve Doubling of Authorized Common Stock to 140 Million
Annovis Bio, Inc. announced that its stockholders have approved an amendment to the company's Certificate of Incorporation, effectively doubling the number of...
Annovis Bio reports preliminary third quarter 2026 cash balance of $2.8 million
Annovis Bio provided a preliminary liquidity update for the third quarter of 2026, disclosing a restricted cash position as it finalizes its quarterly...